相关实验视频
Updated: May 10, 2026

10:10
Quantifying Cognitive Decrements Caused by Cranial Radiotherapy
Published on: October 18, 2011
12.7K
在乳腺癌放射治疗期间应对谦虚:一项多中心研究
Luca Boldrini1,2, Loredana Dinapoli3, Edda Boccia1
1UOC di Radioterapia Oncologica, Dipartimento Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
Breast cancer research and treatment
|May 18, 2024
概括
对于接受放射治疗 (RT) 的乳腺癌患者来说,谦逊是一个重要的关注点. 解决患者的舒适性和隐私问题可以提高他们的整体治疗体验.
科学领域:
- 在瘤学瘤学.
- 辐射疗法 辐射疗法
- 患者体验 患者体验
背景情况:
- 乳腺癌是女性最常见的癌症,放射治疗 (RT) 是一个关键的治疗方式.
- 在RT期间患者的福祉包括身体舒适和情感支持,包括谦虚的考虑.
研究的目的:
- 评估乳腺癌患者接受RT时的谦虚性问题.
- 收集患者关于改善治疗期间隐私和舒适性的建议.
主要方法:
- 555名乳腺癌患者在意大利接受辅助性RT时接受了问卷调查.
- 该调查评估了关于谦虚,与医疗保健专业人员的关系,宗教观点和性行为的舒适度.
主要成果:
- 谦虚是一个普遍的担忧,与一般生活不适有关.
- 患者更喜欢同性保健工作者,尤其是年轻人.
- 手术方法 (乳腺切除 vs 四角切除) 并没有显著影响谦虚感知.
结论:
- 谦虚是乳腺癌患者RT体验的关键因素.
- 需要针对谦虚,沟通和身体形象支持的干预措施.
- 这项研究强调了以患者为中心的护理在放射治疗中的重要性.
更多相关视频
相关概念视频
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

